Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Denmark

Marie Skłodowska-Curie Action · Finished

SHIELD To Shield, or not to Shield: deciphering DNA repair pathway choice after CRISPR-Cas cleavage

Coordinator
Kobenhavns Universitet, Denmark
Runs
1 September 2022 to 31 August 2024
Status
Finished
EU funding
€231k
Total cost
—
Partners
1 organisations in 1 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101061681

What the project is doing

In the project's own words, from its summary on CORDIS.

Genome editing has triggered a revolution with stark implications in life science. Recently, a new gene-editing technique CRISPR-Cas has become dominant in laboratory conditions. The first step in a targeted genome modification requires the CRISPR-Cas nuclease to generate a specific DNA double-strand break (DSB). Eukaryotic cells repair the DSBs by the fast but potentially mutagenic Non-Homologous End Joining (NHEJ), and by the accurate Homology Directed Repair (HDR) pathways.

Gene editing techniques exploit the HDR to modify the DNA to the desired sequence. Usually, it is the NHEJ that repairs the DSBs. That presents a threat of introducing mutations and limits gene editing efficiency and use in medical applications. Moreover, even after entering the HDR pathway, an unclear mechanism involving protein 53BP1 and Shieldin complex blocks the pathway from progressing. My goal is to decipher the 53BP1-Shieldin induced block and then assess Shieldin pathway as a possible therapeutic target to increase the frequency of HDR after CRISPR-Cas cleavage.

The objectives include:1. Reconstitution of the Shieldin pathway in mammalian HEK293 and insect Hi5 cells2. Structural characterization of the protein assembly at DSBs by electron microscopy and mass spectrometry3. Biochemical analysis of the relation between DSB repair and Shieldin pathway In general, the findings can be applied to enhance any gene-editing technique involving a generation of DSBs. Importantly, the results will provide a base for a long-awaited revolution in personalized medicine.

The host laboratory of Prof. Montoya already focuses on improving the properties of the Cas nucleases by means of structural biology and the Shieldin project fits right in their research portfolio. Developing the project will boost my career as new skills in structural biology, including protein electron microscopy, will complement my previous expertise in protein-protein interaction and crosslinking mass spectrometry studies.

Topics

Who is involved

OrganisationCityCountryRole
Kobenhavns UniversitetKobenhavnDenmarkCoordinator

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI